Your browser doesn't support javascript.
loading
Interleukin-6 attenuates serotonin 2a receptor signaling by activating the JAK-STAT pathway.
Donegan, Jennifer J; Patton, Michael S; Chavera, Teresa S; Berg, Kelly A; Morilak, David A; Girotti, Milena.
Afiliación
  • Donegan JJ; Department of Pharmacology and Center for Biomedical Neuroscience, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
  • Patton MS; Department of Pharmacology and Center for Biomedical Neuroscience, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
  • Chavera TS; Department of Pharmacology and Center for Biomedical Neuroscience, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
  • Berg KA; Department of Pharmacology and Center for Biomedical Neuroscience, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
  • Morilak DA; Department of Pharmacology and Center for Biomedical Neuroscience, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
  • Girotti M; Department of Pharmacology and Center for Biomedical Neuroscience, University of Texas Health Science Center at San Antonio, San Antonio, Texas Girotti@uthscsa.edu.
Mol Pharmacol ; 87(3): 492-500, 2015.
Article en En | MEDLINE | ID: mdl-25549668

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Transducción de Señal / Interleucina-6 / Receptor de Serotonina 5-HT2A / Factores de Transcripción STAT / Quinasas Janus Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Mol Pharmacol Año: 2015 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Transducción de Señal / Interleucina-6 / Receptor de Serotonina 5-HT2A / Factores de Transcripción STAT / Quinasas Janus Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Mol Pharmacol Año: 2015 Tipo del documento: Article